|
Category:natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | colorless crystalline needles (est) |
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Refractive Index: | 1.56000 @ 29.00 °C.
|
| Refractive Index: | 1.56890 @ 7.50 °C.
|
| Melting Point: | 48.00 to 49.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 147.00 to 149.00 °C. @ 10.00 mm Hg
|
| Boiling Point: | 156.00 to 158.00 °C. @ 16.00 mm Hg
|
| Vapor Pressure: | 0.001000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 287.00 °F. TCC ( 141.70 °C. ) (est)
|
| logP (o/w): | 1.809 (est) |
| Soluble in: |
| | alcohol | | | water, 2.50E+04 mg/L @ 26C (exp) |
Organoleptic Properties:
| Odor Description:slight creosote |
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | natural substances and extractives |
| Recommendation for 2-hydroxychavicol usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for 2-hydroxychavicol flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| 4- | allyl catechol | | 4- | allyl pyrocatechol | | 4- | allyl-1,2-benzenediol | | 4- | allyl-benzene-1,2-diol | | 4- | allylbenzene-1,2-diol | | 4- | allylcatechol | | 4- | allylpyrocatechol | | 1,2- | benzenediol, 4-(2-propen-1-yl)- | | 1,2- | benzenediol, 4-(2-propenyl)- | | 3,4- | dihydroxy-allylbenzene | | 2- | hydroxy chavicol | | | hydroxychavicol | | 4-( | prop-2-en-1-yl)benzene-1,2-diol | | 4- | prop-2-enyl benzene-1,2-diol | | 4- | prop-2-enylbenzene-1,2-diol | | 4-(2- | propenyl)-1,2-benzene diol |
Articles:
| PubMed:Growth inhibitory response and ultrastructural modification of oral-associated candidal reference strains (ATCC) by Piper betle L. extract. |
| PubMed:Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway. |
| PubMed:A new hydroxychavicol dimer from the roots of Piper betle. |
| PubMed:Piper betel leaf extract: anticancer benefits and bio-guided fractionation to identify active principles for prostate cancer management. |
| PubMed:Identification of hydroxychavicol and its dimers, the lipase inhibitors contained in the Indonesian spice, Eugenia polyantha. |
| PubMed:Antimycobacterial activity of constituents from Foeniculum vulgare var. dulce grown in Mexico. |
| PubMed:Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. |
| PubMed:Simultaneous estimation of hydroxychavicol and chlorogenic acid from Piper betel L. through RP-HPLC. |
| PubMed:Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat. |
| PubMed:Hydroxychavicol inhibits immune responses to mitigate cognitive dysfunction in rats. |
| PubMed:In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. |
| PubMed:Modulation of Th1/Th2 cytokines and inflammatory mediators by hydroxychavicol in adjuvant induced arthritic tissues. |
| PubMed:Biotransformation and cytotoxic effects of hydroxychavicol, an intermediate of safrole metabolism, in isolated rat hepatocytes. |
| PubMed:Hydroxychavicol: a potent xanthine oxidase inhibitor obtained from the leaves of betel, Piper betle. |
| PubMed:Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. |
| PubMed:Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. |
| PubMed:Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase. |
| PubMed:Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. |
| PubMed:Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell carcinoma--evidence for COX-2 induction by areca quid ingredients in oral keratinocytes. |
| PubMed:Isolation and structural elucidation of some glycosides from the rhizomes of smaller galanga (Alpinia officinarum Hance). |
| PubMed:Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species. |
| PubMed:Enhanced hydroxychavicol-induced cytotoxic effects in glutathione-depleted HepG2 cells. |
| PubMed:Role of oxidative DNA damage in hydroxychavicol-induced genotoxicity. |
| PubMed:Hydroxychavicol: a new anti-nitrosating phenolic compound from betel leaf. |
| PubMed:Protective effect of hydroxychavicol, a phenolic component of betel leaf, against the tobacco-specific carcinogens. |
| PubMed:Hydroxychavicol: a new phenolic antimutagen from betel leaf. |
|